Our diversified product portfolio comprises bio-based chemicals, sugar, rectified spirits, ethanol, other grades of alcohol and power. Godavari Biorefineries Limited is the flagship company of the diversified Somaiya Group, which has interests in the education, agricultural research, renewable energy and healthcare industries. Godavari Biorefineries Ltd recently received Indian FDA approval for on
e of their novel lead anti-cancer molecules for Phase-I clinical trials for Triple Negative Breast Cancer (TNBC). The company has also received a patent from the US for this molecule. Godavari Biorefineries has the state of the art R & D facility and is actively involved in anti-cancer drug screening using novel methods. The laboratory has achieved a major breakthrough in developing anti-cancer stem cell molecules which highlight better performance than the standard chemotherapeutic drugs. Company plans to initiate these studies at Clinical trial Sites in India. The trials would be done in TNBC Stage III and IV patients and would take around 6 to 8 months time to complete.